A physiologically-based flow network model for hepatic drug elimination III: 2D/3D DLA lobule models by unknown
RESEARCH Open Access
A physiologically-based flow network
model for hepatic drug elimination III:
2D/3D DLA lobule models
Vahid Rezania1*, Dennis Coombe2 and Jack A. Tuszynski3
* Correspondence:
rezaniav@macewan.ca
1Department of Physical Sciences,
MacEwan University, Edmonton, AB
T5J 4S2, Canada
Full list of author information is
available at the end of the article
Abstract
Background: One of the major issues in current pharmaceutical development is
potential hepatotoxicity and drug-induced liver damage. This is due to the unique
metabolic processes performed in the liver to prevent accumulation of a wide range
of chemicals in the blood. Recently, we developed a physiologically-based lattice
model to address the transport and metabolism of drugs in the liver lobule (liver
functional unit).
Method: In this paper, we extend our idealized model to consider structural and
spatial variability in two and three dimensions. We introduce a hexagonal-based
model with one input (portal vein) and six outputs (hepatic veins) to represent a
typical liver lobule. To capture even more realistic structures, we implement a novel
sequential diffusion-limited aggregation (DLA) method to construct a morphological
sinusoid network in the lobule. A 3D model constructed with stacks of multiple 2D
sinusoid realizations is explored to study the effects of 3D structural variations. The
role of liver zonation on drug metabolism in the lobule is also addressed, based on
flow-based predicted steady-state O2 profiles used as a zonation indicator.
Results: With this model, we analyze predicted drug concentration levels observed
exiting the lobule with their detailed distribution inside the lobule, and compare
with our earlier idealized models. In 2D, due to randomness of the sinusoidal
structure, individual hepatic veins respond differently (i.e. at different times) to
injected drug. In 3D, however, the variation of response to the injected drug is
observed to be less extreme. Also, the production curves show more diffusive
behavior in 3D than in 2D.
Conclusion: Although, the individual producing ports respond differently, the
average lobule production summed over all hepatic veins is more diffuse. Thus the
net effect of all these variations makes the overall response smoother. We also show
that, in 3D, the effect of zonation on drug production characteristics appears quite
small. Our new biophysical structural analysis of a physiologically-based 3D lobule
can therefore form the basis for a quantitative assessment of liver function and
performance both in health and disease
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Background
The liver is a complex organ that removes chemicals, including drugs, from the blood
through metabolic processes. When such liver detoxification processes are incomplete
or overwhelmed, liver damage can result leading to liver failure. Drug access to hepato-
cytes is governed by transport processes in the well-vascularized liver tissue, and so
structural variability can impact such transport. Therefore, a quantitative understanding
of drug distribution and metabolism in the liver is essential for the ability to predict
both liver performance and damage. We envisage a future generation of algorithms for
anatomically- and physiologically-based liver models that can be then used for the pre-
diction of optimal doses and scheduling of various drugs prior to clinical administra-
tion. This could be especially useful for patients with liver diseases such as
hepatocellular carcinoma or cirrhosis.
Several investigators have recently explored computational fluid models of liver lob-
ule function. Ierapetritou et al. [1] give a comprehensive general overview of the model-
ling approaches and issues that arose up to 2009. More particularly, Rani et al. [2]
developed a detailed computational dynamics model of a small portion of a liver lobule,
focusing on the non-Newtonian characteristics of blood. They considered the flow
along one sinusoid with exit fenestrations fed by a portal vein and hepatic artery seg-
ments and exiting via a hepatic vein segment. The contributions of portal vein (PV)
versus hepatic artery (HA) flows to the overall pressure drop and velocity profiles were
detailed, including regions of Eddie flows and high strain rates near the exit fenestra-
tions. Steady state flows were achieved after 5 × 10−5 s.
Yan et al. [3] developed a physiologically-based, multi-agent model of liver lobule
performance. They used a Monte Carlo selection method to determine properties
of the sinusoidal graph structure, convective-dispersive flow and metabolic interac-
tions. This allowed inclusion of lobule zonation effects plus the metabolic influ-
ences of chemical molecular weight, octanol partition coefficients and protein
binding to predicted drug-liver lobule interactions. They matched lobule outflow
characteristics of 4 cationic drugs (atenolol, antipyrine, labetalol, and diltiazem),
using sucrose as a base flow chemical. Wambaugh and Shah [4] compared the role
of various lobule (sinusoidal) morphologies on drug propagation again using an
agent-based simulation approach. While demonstrating that their model can repro-
duce traditional coarse averaging results (well-mixed and parallel tubes) under
some flow regimes, they emphasized the utility of their random statistical approach
for rapidly metabolized chemicals.
Hoehme et al. [5] employed a combined experimental and computational study of
lobule structural restoration after CCl4 damage over several days as a protocol for liver
regeneration. They used agent-based representations of both hepatocytes and sinusoids
in their computational model and demonstrated that the regeneration process is char-
acterized by a hepatocyte-sinusoid alignment process to correctly restore liver micro-
architecture. Schliess et al. [6] extended this approach to consider ammonia
detoxification during liver damage and regeneration. Here they first proposed a simple
metabolic model considering ammonia, urea, and glutamine components utilizing three
mass balance ordinary differential equations (ODEs) for chemical reactions and two
compartments (periportal and perivenal) such that urea generation is maximized in the
periportal region while glutamine regeneration occurs perivenally. The resulting
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concentrations were interpolated on their spatial-temporal grid as the sizes of the dam-
aged zones change over the regeneration process. They also considered a multi-lobule
pattern to reduce boundary effects. Drasdo et al. [7] summarized both modeling ap-
proaches in a review article.
In previous papers (papers I [8] and II [9]), we proposed a physiologically-based
lattice model to study the transport and metabolism of drugs in the liver lobule. In
these studies, we constructed a simple regular square lattice model that represents
a portion of a liver lobule, see Fig. 1a and b, to explore the dynamics of competing
convective, diffusive, and reactive processes acting on an injected chemotherapeutic
drug paclitaxel. Structural and spatial variations and liver lobule zonation were also
considered and their impacts on the hepatic drug metabolism were discussed. Such
simulations had the useful consequence of interpreting drug concentration levels
found exiting the lobule in terms of their detailed spatial distribution within the
lobule, caused by competing processes. This analysis forms the basis, and a point
of contrast, to the drug distributions obtained when some of these basic assump-
tions on lobule structure are relaxed.
In this paper, we extend our biophysical structural analysis to a full lobule
situation, a hexagonal based model with one central blood in-flow (portal vein)
and six corner located out-flows (hepatic veins), see Fig. 1. We also introduce the
sinusoid network using a sequential diffusion-limited aggregation (DLA) algorithm
(as presented and discussed below, Fig. 3) to gain insight on a more realistic
resulting morphological sinusoid structure, see Fig. 1c. In a nutshell, sequential
means a series of DLA generated pattern steps (5 steps) to generate the desired si-
nusoid structure variations in 2D. Thereafter we repeat this algorithm for various
layers to generate a representative 3D lobule pattern. As a result, individual sinus-
oid layers, although generated by the same DLA algorithm, are not identical
Fig. 1 Various flow network structures. a Schematic diagram of a cross section of hepatic parenchyma
consisting hexagonal lobules, portal and hepatic veins. The lobule contains sinusoids and liver cells
(hepatocytes). The segment represents a typical area studied in our previous papers [8, 9]. b Homogeneous
lattice (segmented area) with high porosity bands (in red) representing sinusoids and lower porosity
regions (in blue) representing tissue containing hepatocytes, as in our previous papers [8, 9]. c 2D lobule
lattice with sinusoids generated via a diffusion limited aggregation algorithm, this paper. d 3D lobule
lattice, this paper
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but exhibit some variability as observed in real lobules. A sensitivity analysis is
conducted by observing drug concentration levels exiting the lobule with their pre-
dicted detail distribution inside the lobule.
The liver lobule functional unit
It is commonly accepted that a single lobule serves as the functional unit of the
liver, the smallest structural unit of the liver with ability to perform all hepatic
functionalities [10]. The classic lobule is a hexagonal cylinder, centered around a
hepatic venule and with portal tracts situated at the corners. The portal lobule
has a similar shape but is centered about a portal tract with the hepatic venules
at the periphery [11]. We shall invoke this second point of view as the basis for
our model development.
Even among the approximately 1.5 million lobules (assuming a liver size of
1500 cm3 and a lobule size of 1 mm3) that make up the human liver, structural
variability of lobule units is the rule. Teutsch and colleagues [12] illustrate this
specific microarchitecture variability and diseased states can be expected to add
additional variability. Here we will attempt to quantify the consequences of such
variability via our computational model.
Methods
2D hexagonal lobule construction
The flow equations describing reactive-convective-diffusive flow in the liver lobule re-
main unchanged from our first two papers. Figure 1a and b illustrate the network
structure of our base case model discussed in papers I [8] and II [9] (which uses a regu-
lar sinusoid pattern). Figure 1c represents our model that we study here, which consists
of a 2D square lattice clipped by hexagonal boundary with DLA constructed sinusoid
network. Figure 1d demonstrates a 3D extension of the lobule model that will be
discussed later.
In this paper, MATLAB [13] has been used to code and generate sinusoid network
using a novel sequential DLA algorithm. We use a standard DLA algorithm that ran-
domly clusters a specified number of particles (here Npar) with particle size (dp × dp in
a pixel2). Figure 2a and b show result of DLA runs for Npar = 14,000 and dp = 1 pixel
and for Npar = 7000 and dp = 2 pixel, respectively.
In order to create a hexagonal lobule comparable to a realistic liver lobule, five steps
are taken:
i) A zero Mdim ×Mdim matrix (field) has been created and the DLA algorithm
has been called to create a DLA pattern with specified Npar and dp. A
particle, valued 1, has been located at a random position in the field by the
DLA algorithm and then performed a random walk (with a desired step size,
here denoted by dp) toward the center of the field. The newer particle will
do the same until it hits another (older) particle, sticks to it and stops. This
will continue for all Npar = 9500 particles. See Fig. 3a. Here Mdim = 256 and
dp = 1.
ii) As shown in Fig. 3a, the central region is very crowded. We overwrite the central
region (here we chose half-the original field) using the DLA algorithm and with
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smaller number of zero-valued particles (blue dots). Here we use Ncen1_par = 1200,
Mdim = 128 and dp = 1. See Fig. 3b.
iii)To fill the central region with sinusoids again (red dots), the DLA algorithm will be
called for the third time with fewer particles, i.e. Ncen2_par = 800. Here Mdim = 128
and dp = 2. See Fig. 3c.
iv) In this step, we determine the six corners of the hexagon to create the out-flowing
wells at these locations. Again the DLA algorithm will be used to create a DLA
pattern around each corner. See Fig. 3d. Here we use the domain size of 1/3 of the
original domain, i.e. Mdim/3, and fewer particles, Ncor_par = 500. Here dp = 1.
v) At the final stage, any point outside the bounding hexagon is removed. Figure 3e
shows the final result if the DLA hexagonal lobule. As shown, hepatocytes are blue
islands that are encompassed by red sinusoids.
This sinusoid generation algorithm is similar in spirit but not in details to that
employed by Wambaugh and Shah [14]. They have used the term “sinusoid morph-
ology” to characterize these investigations, which we will also employ. In recent work,
Hoehme et al. [15] captured realistic lobule sinusoid patterns from image analysis of
confocal microscopy of liver tissue. To check whether our simulated sinusoid pattern is
Fig. 2 Diffusion aggregated runs. a Npar = 14,000 and dp = 1 pixel, b Npar = 7000 and dp =2 pixel. Here blue
dots have value of zero representing no particle is on that site (to be used as hepatocytes) and red dots
have value of 1 representing a particle is on the site (to be used as sinusoids)
Fig. 3 Various steps to create a DLA hexagonal lobule. a Main DLA pattern with Npar = 9500 particles and
size dp = 1 on a domain Mdim = 256, b de-crowding the central region using a DLA pattern, c filling the
central region again with a DLA pattern, d creating corner wells using a DLA pattern, e eliminating exterior
points of the hexagon
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comparable with their result, we perform a population density analysis for several 2D
simulated and real lobules (Wisk S, Rezania V: A comparison between real and DLA
simulated liver lobules using a population density analysis, Submitted). We calculated
the ratio of the area covered by sinusoids to the total area of the lobule for both simu-
lated and real 2D lobule images to optimize values of Npar and dp for corresponding
Mdim. Based on these calculations, we find Npar ≈ 37 Mdim (~9500) and dp = 1 will pro-
duce comparable results (~45 % sinusoid area/total 2D area). A comparison of our
Fig. 3d with their results demonstrates that our DLA algorithm with the chosen param-
eters generates equally physiologically reasonable sinusoid morphology patterns (in
particular, see their Fig. 1d or further details in their SI Appendix, their Fig. 3d).
Extension to a 3D lobule structure
In order to generate an even more realistic survey, we next study a 3-dimensional
lobule. Again our morphological sinusoid generation algorithm is similar in spirit
to that employed by Wambaugh and Shah [14] in their 3D models.
The 3D DLA structure is essentially constructed by stacking several 2D DLA
structures as follows:
i) A vertical dimension Mz-dim will be specified.
ii) Starting from the very bottom layer that has a 2D DLA structure, we skip Mskip
layers to introduce the next layer with a 2D DLA structure (a DLA layer), see
Fig. 4a. This procedure will be repeated to reach to the very top layer which again
is a DLA layer. Here, each DLA layer represents the sinusoidal network. Two of
these layers encompass hepatocyte cells (the skipped layers). The value of Mskip is
chosen based on the average thickness size of a hepatocyte cell.
iii)Then, two DLA layers vertically will be connected at several random locations to
approximate the shape hepatocyte cells, see Fig. 4b.
Fig. 4 Three-Dimensional DLA hexagonal lobule for Mz-dim = 97 and Mskip = 2. a A 2D DLA (sinusoid) layer, b
a skipped (hepatocyte) layer, c 3D cutaway view d 3D clipped view
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iv) The center and the six corners of the hexagon in all layers will be connected to
represent arterial and portal veins.
Since the skipped layers represent the hepatocyte tissue, the value of Mskip will be
determined based on the typical volume of a lobule and hepatocytes. The typical vol-
ume of a human liver lobule is somewhat less than 1 mm3 [12]. Furthermore, a hepato-
cyte has a diameter of 12 – 24 μm and thickness of 25 μm in average and mean
sinusoid thickness is about 5 – 7 μm. Here, we chose a sinusoidal cell as a cube with
dimension of 6 μm and a hepatocyte cell as rectangular cube with dimensions 6 μm
and 12 μm, with thickness of 6 μm in the DLA layers and 12 μm in the skipped layers,
respectively. The area of a hexagon with diameter of d is given by S ¼ 3 ﬃﬃﬃ3p d2=8.
In our case, d = 256 × 6 μm= 1536 μm that leads to S = 1.53 × 106 μm2. The 3D lobule
is then composed by stacking up 33 sinusoidal layers and 64 tissue layers (Mz-dim = 97)
that gives an approximate model volume of 1.5 mm3. Here, every two tissue layers are
sandwiched by two sinusoidal layers (Mskip = 2). This choice of tissue/sinusoid grid
thickness represents a compromise between simulation runtime speed and numerical
discretization error.
Figure 4 shows the 3D DLA hexagonal lobule for Mz-dim = 97 and Mskip = 2. Figure 4a
demonstrates a 2D DLA layer representing a sinusoidal layer. Figure 4b shows a hep-
atocyte layer. The red points connect all hepatocyte layers between two DLA layers.
These points approximately determine the boundary of the hepatocyte cells. To con-
struct the third dimension, a DLA layer is created for the bottom, then two hepatocyte
layers (Mskip = 2), and then a new DLA layer will be produced. The procedure repeats
over the whole z-dimension. Figures 4c and d show two different 3D views.
Flow calculation methods
Convection-diffusion-reaction flow calculations are performed on the generated models
utilizing the STARS advanced process simulator [16] as described in our earlier papers.
Here we have chosen paclitaxel (PAC) [17] as our example drug, as it is one of the
most widely used chemotherapy agents, especially active against many human solid tu-
mors [18] (breast cancer, ovarian cancer, lung cancer, etc). Table 1 summarizes our base
Table 1 Base case flow and metabolism parameters
Parameter Characteristic (SI) Unit STARS Unit
Sinusoid Porosity ϕsin 0.7854 0.7854
Sinusoid Permeability Ksin 1.125 μm2 1.140 Darcya
Sinusoid Effective Diffusion Dsin 4.2 × 10
−10 m2/s 2.5 × 10−4 cm2/min
Tissue Porosity ϕtis 0.2382 0.2382
Tissue Permeability Ktis 7.35 × 10
−2 μm2 7.45 × 10−2 Darcy
Tissue Effective Diffusion Dtis 4.2 × 10
−11 m2/s 2.5 × 10−5 cm2/min
Maximum Rate vmax
b 0.06 μM/min 1.08 × 10−9 mole fraction/min
Half Saturation Constant Km
b 10.0 μM 1.8 × 10−7 mole fraction
Linear Rate vmax/Km
b 6.0 × 10−3 min−1 6.0 × 10−3 min−1
Blood Viscosity μ 3.5 × 10−3 Pa-sec 3.5 cpoise
a 1 Darcy = 0.9869 μm2 in engineering permeability units
b PAC kinetic elimination Michaelis-Menten parameters converted from Vaclavikova et al. [17], their Table 4
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case flow and metabolic parameters for PAC (from Vaclavikova et al. [19]) used in these
calculations for a representative human lobule. Cytochrome P450 CYP2C8 or CYP3A4
[20] are the enzymes active in PAC metabolism. Due to the non-regular areal sinusoidal
structures generated here, however, it was found necessary to utilize a higher order
discretization method (“areal 9-point”) to produce the expected smooth profiles on
these grids. A discussion of this (quite standard) discretization method can be found in
the STARS manual.
Results and Discussion
2D drug distribution – comparison to our earlier studies
Similar to previous studies, flow is induced in the lobule lattice by applying a pressure
difference across the central inlet and six corner outlet points. With the chosen lobule
flow parameters for porosity, permeability, and blood viscosity, the steady flow rate is
4.491× 10−6 cm3/min with (0.4077, 0.3011, 0.1950, 0.9682, 0.2251, 2.394) × 10−6 cm3/
min for ports A to F, respectively, as illustrated in Fig. 5. (For steady flows, the inflow
rate equals the total outflow rate.) It is clear that ports D and F have highest outflow
among the others. This is due to the random nature of the DLA simulation for this
realization.
Figure 6 demonstrates the steady state velocity profile throughout the lobule lattice,
illustrating both the diverging/converging nature of the flow near the inlet and outlet
ports (i.e. injector and producers, respectively), as well as the orders of magnitude dif-
ference of the flows in the sinusoids and tissues, respectively. (This plot uses a logarith-
mic colour scale axis). Ports D and F show highest velocities among the ports.
Blood with a relative composition of 1 microgram PAC (1.8 × 10−8 mole fraction) is
infused into the lobule through the central inlet. Assuming nonreactive hepatocytes,
the time required to traverse the lattice is approximately 1 min or less as demonstrated
in Fig. 7. The fastest drug propagation is through ports D and F for this realization.
Similar to our Paper I [8], this production profile is convective flow dominated as the
addition of diffusion minimally alters the production profile (figure not shown).
As indicated in our Paper II [9] concerning variable lattices models with multiple re-
alizations, flow induced by the application of a fixed pressure drop across a lobule
model can be expected to vary significantly for each model realization. This will in turn
Fig. 5 Injected flow (PAC). Steady state flow across the 2D lobule
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impact on the propagation and production characteristics of both non-reactive and me-
tabolized drugs. Thus multiple realizations of the morphological sinusoidal network
generated by our DLA algorithm here induce a similar variability in flow and drug pro-
duction behavior. Table 2 summarizes the flow variability for 16 such realizations. In
what follows, we will focus on the analysis of drug behavior for one such realization.
The spatial progression of the PAC concentration on the lobule lattice without and
with diffusion is demonstrated in Figs. 8 and 9, respectively. The diffusion constants for
PAC and PAC-OH are estimated as 2.5 × 10−4 cm2/min in sinusoid and 2.5 × 10−5 cm2/min
in tissue, respectively. In the absence of diffusion, only a small “pressure-difference-driven
(convective)” transfer from sinusoids to tissue through the space of Disse is occurring. See
our Paper I [8] for details.
Figures 8 and 9 show the increasing levels of injected drug from 0.01 min to 5 min
(0.5 min in case with diffusion). As shown, by 0.01 min, PAC almost reaches the out-
going port F of the lobule.
In case with no diffusion, it takes almost 5 min to fill the lobule (Fig. 8), while PAC
completely covers the lattice after 0.5 min when diffusion is on as demonstrated in
Additional file 1: Figure S1.
Fig. 6 Steady state velocity profile across the 2D lobule. Color bar is in cm/min
Fig. 7 Non-reactive PAC drug propagation across the lobule without diffusion effects
Rezania et al. Theoretical Biology and Medical Modelling  (2016) 13:9 Page 9 of 22
Reactive flows in 2D
Now we consider the effects of PAC drug metabolism by hepatocytes. Here the base
case reaction parameters of Table 3 of Paper I [8] are employed, and the same injected
PAC concentration (1.8 × 10−8 mole fraction) is considered. With the employed reac-
tion half saturation constant value of 1.8 × 10−7 mole fraction, this injection level im-
plies the Michaelis-Menten model reduces to an almost linear reaction equation.
Table 2 Flow rate variability of multiple 2D DLA sinusoid morphologies



















Fig. 8 Non-reactive PAC profiles across the lobule without diffusion. a PAC at 0.01 min, b PAC at 0.1 min, c
PAC at 0.2 min, d PAC at 5 min. Color bar is in mole fraction
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Figure 9 illustrates injected drug and produced drug and metabolite production for
this case. The reaction rate is 6 × 10−3 min−1. Again it is emphasized that both PAC
and PAC-OH have assumed equal diffusive flow contributions, as these are compo-
nents of very similar size. Essentially at this reaction rate, all injected PAC is converted
to metabolite by the lobule hepatocytes. The production profile of PAC-OH here is
similar to the production profile of PAC in the non-reaction case, as shown in Fig. 7,
for most of the ports. That is, the reactive conversion of PAC to PAC-OH occurs rea-
sonably quickly. However, for the two ports with higher flows (ports D and F), less con-
version of PAC to PAC-OH is seen to occur.
Figure 10 shows the PAC and PAC-OH profiles across the lobule lattice at 0.01 min,
0.10 min, and 0.20 min, respectively. The PAC concentrations in the sinusoids and the
PAC-OH concentrations in the tissue are equivalent to the PAC concentrations in both
sinusoids and tissue for the non-reacted case (Fig. 8). Note that after 0.1 min there is
no change in PAC spatial distribution as it converts to PAC-OH before propagating fur-
ther. Figure 10 also shows clearly there is an inlet distance over which the reaction con-
version time is not fast enough to convert the injected PAC.
Fig. 9 Reactive (6 × 10−6 min−1) PAC (solid lines) and PAC-OH (dashed lines) drug propagation across the
lobule, without diffusion effects and base case metabolism
Fig. 10 Reactive (6 × 10−6 min−1) PAC and PAC-OH profiles across the lobule without diffusion effects and
base case metabolism. a PAC at 0.01 min, b PAC at 0.10 min, c PAC at 0.20 min, d PAC-OH at 0.01 min, e
PAC-OH at 0.10 min, f PAC-OH at 0.20 min. Color bar is in mole fraction
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Diffusion, however, has greater impacts on the reactive cases. Figure 11 compares
the overall PAC to PAC-OH conversion for two reactive cases with reaction rate
6 × 10−6 min−1 and 6 × 10−3 min−1, with and without diffusion. (The latter rate is our
base case which has the higher conversion rate.) As shown, at each rate a greater con-
centration of PAC-OH is generated when diffusion is on, as this provides an additional
mechanism to bring PAC molecules to the reactive hepatocyte sites.
3D drug distribution – extension of behaviors
As stated above, the 3-dimensional lobule is constructed by stacking up 33 sinusoidal
layers and 64 hepatocyte layers (Mz-dim = 97) with the approximate volume of 1.5 mm
3.
The sinusoidal layers have similar structures (randomly generated though) as the 2D
DLA lobule structure discussed in previous section. The hepatocyte layers are gener-
ated by randomly selected points to mimic hepatocyte cell distribution in a lobule. All
layers are connected through the central region (the portal vein) as well as six corners
of the hexagon (hepatic veins). In this section we are interested in studying the effect of
the third dimension as the blood will be injected from the central vein in all layers
simultaneously.
In 3D, the steady flow rate across the full lobule is 3.00× 10−3 cm3/min as shown in
Fig. 12a, as all volumes have been upscaled from our 2D slice models. As seen in
Fig. 12b and c, in this realization of the 3D lobule, ports A and F have highest outflow
(they are essentially superimposed), then ports B and D (they are essentially superim-
posed), with C and E having the lowest outflow rates. This is again due to the random
nature of the DLA simulation for this realization. However the port-to-port variation in
Fig. 11 Reactive PAC-OH drug propagation across the lobule, with and without diffusion effects. For two
reaction kinetics 6 × 10−6 min−1 (curves with circle) and 6 × 10−3 min−1
Fig. 12 Non-reactive PAC drug propagation across the lobule in 3D. a steady state flows across the 3D
lobule (b) PAC propagation without and (c) PAC propagation with diffusion effects
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flows is significantly less extreme in 3D, as the third dimension provides additional
connecting flow paths to smooth the overall flow pattern.
Figure 13 gives a spatial view (clipped–view) of the increasing levels of the injected
PAC drug from 0.01 min to 1 min across the lobule without diffusion and no reaction.
The drug first clearly follows the high flow paths provided by the morphological sinus-
oid network, and only slowly reaches into the tissue portions of the lobule. A different
spatial view (block–view) is also demonstrated in Additional file 2: Figure S5.
The same two views of non-reactive PAC injection with diffusion added are shown in
Additional file 3: Figure S2 and Additional file 4: Figure S3. In those figures the
sinusoid-tissue transfer rate is much more rapid and PAC drug propagates in a more
uniform fashion as it enters the lobule. Clearly, diffusion has a very significant effect on
the drug propagation details although at later times both cases result in a uniform drug
coverage of the lobule.
Reactive flows in 3D
Now we consider the effects of PAC drug metabolism by hepatocytes across the 3D
lobule. Similar to the 2D case, the same injected PAC concentration (1.8 × 10−8 mole
fraction) is considered.
Figure 14 illustrates injected drug and produced drug and metabolite production for
this case without and with diffusion effects. The reaction rate is 6 × 10−3 min−1. As
before, both PAC and PAC-OH have assumed equal diffusive flow contributions.
Figures 14a and b demonstrate the levels of PAC and PAC-OH, respectively, without
including diffusion effects. As shown, both PAC and PAC-OH have similar concentra-
tions after 1 min in all outlets (i.e. approximately half of injected PAC is metabolized to
PAC-OH). The diffusion, however, alters the latter behavior significantly as depicted in
Fig. 14c and d. All the PAC converted to PAC-OH almost immediately. The variability
Fig. 13 Non-reactive PAC profiles across the lobule without diffusion in 3D – clipped view. a PAC at
0.01 min, b PAC at 0.05 min, c PAC at 0.1 min, d PAC at 1 min. Color bar is in mole fraction
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of the produced PAC-OH concentration per port for this reactive case with diffusion
mirrors the variability of the produced PAC per port for the nonreactive case (Fig. 11,
with or without diffusion).
Figure 15 shows the spatial clipped-view of reactive PAC and PAC-OH distributions
in the 3D lobule at selected times without diffusion effects and with the base case me-
tabolism rate. As time progresses, more PAC is metabolized to PAC-OH but the meta-
bolic rate is low enough that both PAC and PAC-OH distribute throughout the lobule.
This distribution is not uniform throughout the lobule however. For example, there re-
mains an inlet zone with a negligible amount of PAC-OH at all times. The spatial
block-view is also demonstrated in Additional file 5: Figure S6.
As shown in Additional file 6: Figure S4, with diffusion but still utilizing a base case
metabolic rate, the in-situ conversion of PAC to PAC-OH is much more rapid and uni-
form, and results in an almost total drug conversion to PAC-OH throughout the 3D
lobule. There remains only a small inlet region of unconverted PAC.
Fig. 15 Reactive (6 × 10−3 min−1) PAC and PAC-OH profiles across the lobule without diffusion effects and
base case metabolism in 3D – clipped view. a PAC at 0.01 min, b PAC at 0.05 min, c PAC at 0.1 min, d PAC
at 1 min, e PAC-OH at 0.01 min, f PAC-OH at 0.05 min, g PAC-OH at 0.10 min, h PAC-OH at 1 min. Color bar
is in mole fraction
Fig. 14 Reactive (6 × 10−3 min−1) PAC and PAC-OH drug propagation across the lobule in 3D. a PAC
without diffusion, b PAC-OH without diffusion, c PAC with diffusion, d PAC-OH with diffusion
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As in the 2D cases presented earlier, diffusion has greater impact on drug distribution
for the reactive cases. Similar behaviors can be observed for other reaction rates
(e.g. reaction rate 6 × 10−1 min−1) with and without diffusion (not shown).
3D drug distribution with zonation
Zonation is a well-known feature of many metabolic processes in the liver lobule [15],
some processes are up-regulated in the periportal region, while others are up-regulated
in the perivenal region. Here we consider zonation of drug metabolizing enzymes
(in particular cytochrome P450 – CYP2C8), such that higher CYP levels are found
near the perivenal region.
Zonation has been attributed primarily to a non-uniform distribution of O2 across
the lobule [16]. Here we will utilize this experimental observation to predict relative
CYP levels based on a calculated O2 distribution. Appendix A presents details of the
O2 convective-diffusive-reactive flow problem employed to generate the zoned-CYP
distribution.
The resultant initial non-homogeneous distribution of CYP enzymes is imported
into the PAC reaction model in a manner analogous to that employed in our earlier ideal-
ized model of zonation [9]. Here we consider enhanced perivenal enzyme expression (the
“reversed” case of reference [9]) as a reference, where CYP expression is active primarily
near the lobule outlet zone. In our present work, two scenarios are envisioned: (a) a CYP
distribution generated from “normal” levels of O2 injection, and (b) that generated from a
“low concentration” O2 injection level. The result is shown in Figures A3 and A4, which
can be contrasted to Additional file 3: Figure S2b of our earlier idealized model [9]. These
distributions are used to modify the PAC metabolic rates non-homogeneously in a man-
ner similar to our earlier paper.
Figure 16 compares reactive PAC and PAC-OH production profiles with no diffusion
contributions to the flow. Note that both PAC and PAC-OH are produced here as in
our ideal treatment of zonation found in Paper II [9]. In Fig. 16 only ports A and C are
shown as their productions show the largest variation among all six production ports.
Zonation (either averaged or extreme) is seen to have a small effect on the production
behavior compared to the base case (no zonation) behavior, with the low concentration
zonation profiles essentially identical to the no zonation case (see the almost uniform
CYP profile generated for this case, Figure A3). Finally, with the same (reversed) zon-
ation patterns, but assuming additional diffusive contributions to the flow, mostly only
PACOH is produced, and no differences in production behavior are seen with or
Fig. 16 Reactive (6 × 10−3 min−1) PAC and PAC-OH profiles across the lobule without diffusion effects and
normal versus low concentration–zonation metabolism (a) PAC production (b) PAC-OH production
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without zonation (not shown). This is consistent with our ideal treatment of zonation de-
scribed in Paper II [9].
Spatial plots of PAC and PACOH distributions at various time points for the no diffu-
sion cases with zonation show only subtle differences from the base case no-zonation pro-
files of Fig. 16 and thus are not shown explicitly. This is perhaps not surprising for the
low O2 concentration generation case with a very uniform zoned CYP distribution, but is
more puzzling for the normal O2 concentration generated case. We believe this is a result
of the high PAC to PACOH conversion rate chosen as our example for this paper coupled
to the downstream distribution of CYP. This example appears to be quite robust to details
of the exact CYP zonation pattern.
To further confirm these comments, we have rerun the models with a lower PAC me-
tabolism rate. Figure 17 compares reactive PAC and PAC-OH production profiles with no
diffusion contributions to the flow at these lower reaction rates (6 × 10−6 min−1). Again
only ports A and C are shown. For these cases, the low concentration zonation produc-
tion is again essentially identical to the no zonation case, but the normal zonation produc-
tion differs more substantially from the other two cases. This behaviour is reflected in the
spatial distributions of PAC and PACOH at various time points as well. Figure 18 com-
pares the final (at 1 min) spatial distributions for PAC and PACOH for the normal and
low-oxygen concentration generated CYP distributions. (The no zonation case is essen-
tially identical to the latter case plots, not shown). The normal oxygen generated CYP dis-
tribution results in less PACOH conversion.
Conclusions
Generalized conclusions relative to our earlier work
The increased morphological variability of the sinusoidal networks generated in this
work allows various generalized observations relative to our earlier work on idealized
lattice models:
(a) In 2D due to randomness of the sinusoid patterns, individual producing ports
(hepatic veins) respond differently (i.e. at different times) to injected drug. This is
similar to the randomness we generated via multiple realizations to our individual
well pair models with our previous idealized modelling work. If we sum the
individual hepatic vein responses we get an overall 2D lobule drug response (see
Fig. 5), the net result of which is an increased spreading (effective diffusion) of the
average produced profile.
Fig. 17 Reactive (6 × 10−6 min−1) PAC and PAC-OH profiles across the lobule without diffusion effects and
normal versus low concentration–zonation metabolism (a) PAC production (b) PAC-OH production
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(b)Multiple 2D morphological sinusoid realizations can be explored to ascertain
the effects of structural variations, as indicated in Table 2. Additionally a 3D
model viewed as interacting stacks of 2D sinusoid realizations represents an
enhanced method to consider such variability.
(c) In 3D, because the individual producing ports are completed throughout the
vertical extent of the lobule, the variation of response of individual producing
ports is seen to be less extreme, although the production curves themselves are
more diffuse in 3D than in 2D. Furthermore, the average lobule production
summed over all hepatic veins is also more diffuse. Thus the net effect of all
these variations is to make the overall response more smooth (i.e. more robust
to individual variations).
(d)When the effect of drug processing (CYP) zonation is included, the effect on
drug production characteristics appears quite small and only when the further
(smoothing) effects of diffusion are ignored. However, within a lobule we expect
there are conditions under which there can be noticeable differences in drug
distribution due to zonation. These observations are consistent with our earlier
idealized models of zonation. Finally we should emphasize that this treatment of
zonation of drug metabolism can be readily extended to other metabolic zonation
phenomena occurring in the liver, such as carbohydrate metabolism [21], nitrogen
metabolism [22], etc. O2 distribution is implicated as a fundamental cause of such
zonation in all cases.
Follow-up work and future directions
Since various liver diseases can be thought to produce structural variations in the
lobule, our analysis also gives insight into the role of disease on liver function and
Fig. 18 Reactive (6 × 10−6 min−1) PAC and PAC-OH profiles at 1 min across the lobule without diffusion
effects and normal versus low concentration-zonation metabolism in 3D – clipped view. a PAC
(normal concentration), b PAC-OH (normal concentration), c PAC (low concentration), dPAC-OH
(low concentration). Color bar is in mole fraction
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performance. In our previous work on variable lattice lobule models [9], we utilized
random sinusoid permeability models and percolation concepts to capture some of the
structural effects of hepatitis and cirrhosis. We next plan on extending such analysis to
our more physiologically realistic 3D lobule model.
It should be mentioned that there exist other computer-generated liver models that
attempt to provide a realistic representation of the liver vasculature for blood flow and
metabolic reaction simulations. Schwan et al. [23] used an image of a mouse liver pro-
duced with a CT scanner. Based on this image data, they reconstructed the structure of
the fine branches of the liver vessel system. The liver was then split into 50,000 small
blocks. The results of the simulation show that blood flow and metabolic reactions
can be tracked in detail on the computer monitor. In a follow-up publication [24] a
multi-scale model was generated that links together four scales of modeling. Thus the
focus of these authors is the full liver scale (organ model) and not the lobule scale (tissue
level) which is the subject of our current paper. In addition, we have also recently devel-
oped a spatial model of the full liver (White D, Rezania V, Coombe D, Tuszynski J: Build-
ing a 3D virtual liver: a preliminary example – methods for describing vascular
generation, blood flow calculations, and hepatic clearance, submitted) utilizing a
computational algorithm for generating vasculature and where we have considered
upscaling from our lobule model and some comparisons with the work of Schwen
et al. [23]. Eventually, our overall modeling approach is intended to provide input
data regarding liver metabolism for multi-compartment physiologically-based phar-
macokinetic models such as those reviewed by Jones et al. [25]. This could lead to
more accurate and individualized predictions for the pharmacokinetic analyses of
drugs and drug combinations. It is also of interest to explore the possibility of
fractal vascular structures and their consequences on the scaling laws in liver func-
tion as reviewed extensively by Pang et al. [26].
Our focus will continue to be on the structural and metabolic changes induced
by liver disease and cancer, and its remediation via drug treatments. More particu-
larly, we will focus on drug combination therapy for cancer (e.g. paclitaxel with
doxorubicin) [27].
Appendix A
Reactive O2 distribution in 3D – indicator of zonation
Here we utilize known O2 flow characteristics to predict steady state O2 distributions
across our mathematically constructed 3D liver lobule. The O2 reactive flow character-
istics are taken from Davidson et al. [28], and are summarized in Table 3. Davidson
et al. [29] utilized this data to analyze O2 behaviour in their bioartificial liver. Here we
will employ the same data to predict O2 distribution across our 3D lobule model.
The O2 metabolic reaction used in our model is assumed to be
O2 þ HEP→1:778 H2O þ HEP
This approach preserves mass and assumes a non-specific metabolic consumption of
O2 by hepatocytes without detailing explicit cellular metabolic products (since water is
a universal component in our model). Reactions occur only in tissue areas (hepatocytes
HEP act as “catalysts” for this reaction).
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With these parameters, the flow of O2 across the lobule is calculated in a manner simi-
lar to that of reactive PAC. O2 levels are due to the relative contribution of convection,
diffusion and hepatocyte O2 consumption. Note, however, the flow pattern of O2 can be
expected to be quite different from that of PAC, both because of its reaction rate but also
because of its diffusion coefficient, as this is a very small molecule with much higher diffu-
sion than PAC. Here we establish a steady state O2 distribution throughout the 3D lobule
by observing the long time O2 distribution.
Two cases are considered: (a) “normal” O2 injection levels, and (b) “low concentration”
O2 injection levels to represent some nonspecific illness condition, as listed in Table 3.
[(a) 90 mm Hg = 3.37 × 10-6 mole fraction; (b) 60 mm Hg = 2.25 × 10−6 mole fraction].
Figures 19 and 20 illustrate the evolution of O2 profiles across the lobule to steady state
for these two cases, respectively. Although there are observable concentration differences
between the two cases throughout the lobule, the major differences occur near the injec-
tion site.
Rescaled versions of these distributions are used to define corresponding predicted
CYP distributions. The actual form of this rescaling is
CYP½  ¼ 1:0 ‐ O2½ ‐ O2½ min
 
= O2½ max‐ O2½ min
 
Table 3 O2 kinetic elimination Michaelis-Menten parameters plus diffusion (converted from
Davidson et al. [28], their Table 1)
Parameter Characteristic unit STARS unit
Maximum Rate vmax 352 μM/min 6.34 × 10
−6 mole fraction/min
Half Saturation Constant Km 6.24 μM 1.12 × 10
−7 mole fraction
Linear Rate vmax/Km 56.4 min
−1 56.4 min−1
Sinusoid Effective Diffusion 3.0 × 10−9 m2/sec 1.8 × 10−3 cm2/min
Tissue Effective Diffusion 2.0 × 10−9 m2/sec 1.2 × 10−3 cm2/min
Fig. 19 Reactive O2 profiles across the lobule with diffusion effects for “normal” injected O2 level in
3D – clipped view. a O2 at 0.01 min, b O2 at 0.1 min, c O2 at 0.5 min, d O2 at 1.0 min. Color bar is in
mole fraction
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Here [O2] >0 represents the steady state O2 concentration level at any location
throughout the lobule for each case, while [O2]min and [O2]max correspond to the
non-zero minimum and maximum injected O2 concentration level for the “normal”
case (90 mm Hg = 3.37× 10−6 molefrac), respectively. Figure 21 shows the resultant
CYP profiles for each case. First, there are zero CYP expressed in the sinusoids
and near the injection end for the “normal O2 generated” zonation. There are
higher CYP levels generated near the production ports, but the individual CPY
levels depend on the flow distribution to each port (the ports with highest flow
have lower CYP levels). In contrast, for the “normal O2 generated” zonation, there
is significantly higher levels of CYP predicted and a much more uniform distribu-
tion (except closest to the inlet port).
These zonal CYP distributions are used in the main body of the paper to investigate
PAC drug zonation effects.
Fig. 21 Predicted CYP profiles across the lobule for injected O2 level in 3D – clipped view. a Normal
concentration, b low concentration. Color bar is normalized
Fig. 20 Reactive O2 profiles across the lobule with diffusion effects for “low concentration” injected O2 level
in 3D – clipped view. a O2 at 0.01 min, b O2 at 0.1 min, c O2 at 0.5 min, d O2 at 1.0 min
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Additional files
Additional file 1: Figure S1. Non-reactive PAC profiles across the lobule with diffusion. (a) PAC at 0.01 min, (b)
PAC at 0.1 min, (c) PAC at 0.2 min (d) PAC at 0.5 min. Color bar is in molfrac. (PPTX 206 kb)
Additional file 2: Figure S5. Non-reactive PAC profiles across the lobule without diffusion in 3D – block view. (a)
PAC at 0.01 min, (b) PAC at 0.05 min, (c) PAC at 0.1 min (d) PAC at 1 min. Color bar is in molfrac. (PPTX 613 kb)
Additional file 3: Figure S2. Non-reactive PAC profiles across the lobule with diffusion in 3D – block view. (a)
PAC at 0.01 min, (b) PAC at 0.05 min, (c) PAC at 0.1 min (d) PAC at 1 min. Color bar is in molfrac. (PPTX 431 kb)
Additional file 4: Figure S3. Non-reactive PAC profiles across the lobule with diffusion in 3D – sliced view. (a)
PAC at 0.01 min, (b) PAC at 0.05 min, (c) PAC at 0.1 min (d) PAC at 1 min. Color bar is in molfrac. (PPTX 335 kb)
Additional file 5: Figure S6. Reactive (6 × 10-3 min-1) PAC and PAC-OH profiles across the lobule without
diffusion effects and base case metabolism in 3D – block view. (a) PAC at 0.01 min, (b) PAC at 0.05 min, (c) PAC at
0.1 min, (d) PAC at 1 min, (e) PAC-OH at 0.01 min, (f) PAC-OH at 0.05 min, (g) PAC-OH at 0.10 min, (h) PAC-OH at
1 min. Color bar is in molfrac. (PPTX 1050 kb)
Additional file 6: Figure S4. Reactive (6 × 10-3 min-1) PAC and PAC-OH profiles across the lobule with diffusion
effects and base case metabolism in 3D – sliced view. (a) PAC at 0.1 min, (b) PAC at 0.5 min, (c) PAC at 1 min, (d)
PAC-OH at 0.1 min, (e) PAC-OH at 0.5 min, (f) PAC-OH at 1 min. Color bar is in molfrac. (PPTX 378 kb)
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